ESG News For Gilead Sciences, Inc.

Take a spin through the latest in Gilead’s science and innovation in our new series, The Centrifuge Sessions.

Lead PURPOSE researcher Moupali Das, Vice President, Clinical Development, HIV Prevention & Pediatrics, designed the PURPOSE program with Gilead’s person-centric approach in mind to reach underserved communities and groups around the world.

The Children’s Inn at the National Institutes of Health (NIH) today announced that Gilead Sciences Inc. has awarded The Inn a $1 million grant to support its renovation and expansion. The grant will fund a welcome center in the new wing of The Inn of Tomorrow, a $50-plus million project for which The Inn recently held a groundbreaking ceremony. As the first point of contact, The Gilead Sciences Welcome Center is designed to ensure young patients from around the world participating in groundbreak

Lauren Huffmaster received a late-stage metastatic breast cancer (mBC) diagnosis in 2015 and soon discovered there wasn’t a lot information to help explain to her young children what she was going through.

Improving health outcomes and reducing barriers to care starts in our own backyard. That’s why the Gilead Foundation’s HEAL Initiative is dedicating $5 million to helping build a Bay Area healthcare workforce that’s more diverse and representative of the patient population

We're prioritizing health equity for patients across the cancer care continuum. Our Gilead Oncology Grant supports 22 U.S. organizations with $3.15 million to provide resources for people affected by breast cancer.

Despite major advances in scientific innovation, access to care and growth of health systems, there are still millions of people around the world living with HIV.

As a young gay professional, Terrell Parker spent several years working at the National Minority AIDS Council in Washington, D.C. during his 20s, advocating to help end the HIV epidemic and reduce stigma.

Together for a Cure: Fundraising Event Aims to Unite the Community for Breast Cancer Research and Support

Jackson Egen learned the value of basic lab research as a graduate student at UC Berkeley in the 90s while working under the direction of renowned immunologist James Allison.

Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we’ll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.

This year, we’re among 42 organizations being recognized by Seramount as a Leading Inclusion Index Company.

Maria underwent many more medical tests until a fibroscan conducted in 2018 by a hepatologist revealed that she had a rare autoimmune liver disease called primary biliary cholangitis, or PBC.

Transformative medicines have the greatest impact when they reach the people who need them most.

Cancer can cause disruption for families and may especially impact children.

Dr. Summer Sitima is one of 24 siblings born to a Kenyan family in the 90s at the height of the HIV epidemic in Sub Saharan Africa. She vividly remembers the day in 1997 that she first learned one of her older sisters was living with HIV.

For the third year in a row, Forbes has recognized Gilead as one of America’s Best Employers For Women.

Gilead Sciences, Inc. and the Elton John AIDS Foundation announced a five-year extension of the RADIAN ® partnership to help meet the needs of the most vulnerable key populations in Eastern Europe and Central Asia (EECA) where the HIV epidemic is growing.

As a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals.

Jim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human Resources team.

Gilead and Kite Pharma teams raised Pride Month flags at our campuses last week symbolizing our united support for LGBTQ+ communities globally.

Luciana is a physician with more than 20 years of experience in pharma and she came to Gilead to help transform treatments for people living with cancer.

Gilead partners with various organizations that support people living with breast cancer. One such organization, the Young Survival Coalition (YSC), recognizes the unique needs of people of childbearing age and works with patients under 40.

In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking to improve access and use of cancer screenings.

Driven by our purpose to make the world a healthier place for all people, we’ve worked to improve health equity and advance equitable access to care.

Olivia Sloan was pursuing a career in health policy and research when her father was diagnosed with non-Hodgkin lymphoma. The devastating news put her work on hold as she returned home to Santa Fe, New Mexico to help care for her dad.

A 22-year-old college student who didn’t feel well was treated at an urgent care facility in Baton Rouge, Louisiana and expected to recover soon.

James had been free from using drugs for a decade when a routine test at his local health center revealed he had hepatitis C (HCV).

Forbes has listed Gilead as one of America’s Best Employers for Diversity. We believe that by championing inclusion and diversity, we not only enrich our workplace but also drive groundbreaking advancements in science.

Learn how we’re advancing our vision to create a healthier world while benefiting our people, the communities we support and our planet.

Women represent more than half of Gilead’s workforce, and our weighted salary ratio for women to men globally in 2023 was 99.93:100. We'll continue our efforts to champion an environment of equality and inclusion for all.

Dr. Thomas Odeny grew up in rural Kenya during the height of the HIV epidemic in sub-Saharan Africa. After graduating from medical school at the University of Nairobi, he decided to begin his career in HIV care as a way to give back to his community.

In the summer of 2019, Bora was celebrating his mother’s birthday at a seaside restaurant in Istanbul when he suddenly became very ill and couldn’t finish his meal.

We’re committed to increasing diverse representation in clinical trials, especially for those who have been historically underrepresented.

Dale, who is living with breast cancer, shares her journey and point of view about how sharing information can help reduce health disparities.

At Gilead, we’re focused on fighting devastating diseases and delivering innovative medicines that offer new hope for patients. Also important, though, is our work to make sure that we remove barriers to care and reach the people that need our therapies.

This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.”

Gilead Sciences, Inc. (Nasdaq: GILD) announced it is providing a total of $12.6 million in grant funding to 19 organizations working to improve the HIV landscape for Black women and girls in the United States.

This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.”

Gilead Sciences, Inc. (Nasdaq: GILD) announced the company has been named one of America’s Most JUST Companies.

Long-time liver specialist Carrie Frenette says she won’t ever forget the people she treated for hepatitis C (HCV) before 2013 – the year that the Food and Drug Administration (FDA) approved a Gilead medicine. The medicine was the first curative therapy for HCV.

We’re proud to offer an inclusive culture that enables all people to do their best work, and we’re happy to be named one of Newsweek America’s Greatest Workplaces for Diversity for our efforts.

The personal journeys of six people in the United Kingdom living with HIV, hepatitis C and cancer – and the challenges they face due to stigma and health inequities – come together in the form of a new, intentionally difficult-to-read book from Gilead.

For the past 30 years, Pilar Fernandez has navigated living with metastatic breast cancer. And while she’s faced a series of related health challenges, it hasn’t slowed her down.

“It's an experience that I hope no one goes through, but it's an empowering experience.” 

When employees at Gilead’s recently opened New Jersey office need a place to meet, the “Cara” conference room is one such place they gather. Given the room’s namesake, it’s especially fitting when the topic at hand is the company’s oncology work.

Gilead Sciences, Inc. (Nasdaq: GILD) announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index (DJSI World) for the third consecutive year.

We're proud to have contributed to this milestone announced by the World Health Organization - marking the elimination of visceral leishmaniasis (VL) as a public health problem in Bangladesh.

When Shirley Cantin was a law student, about half of her classmates were women. Yet when she joined a corporate law firm, Shirley noticed that most of its leaders were white men. And when she left a decade later, little progress on the leadership team’s diversity had been made.

– Gilead Also Included on the Dow Jones Sustainability North America Index; Rankings Reflect Gilead’s Ongoing Commitment to Corporate Responsibility –– DJSI World Highlights the Most Sustainable Companies Around the World Based on Corporate Sustainability Assessment –